AIM2	absent in melanoma 2
AP-1	activator protein-1
BMP	bone morphogenetic protein
DAMPs	danger-associated molecular patterns
DNMT1	DNA methyltransferase 1
ECM	extracellular matrix
EMT	epithelial−mesenchymal transition
En1	Engrailed-1
EndMT	endothelial cells to mesenchymal cells
ERs	estrogen receptor
Fli1	Friend leukemia virus integration 1
HIF-1	hypoxia-inducible factor-1
HMGB1	high-mobility group box-1
HS	hypertrophic scars
IL-1β	initiators interleukin-1beta
IL-4Rα	interleukin-4 receptor α
LC	Langerhans cells
LH2	lysyl hydroxylase 2
lncRNAs	long non-coding RNAs
LRG-1	leucine-rich-alpha-2-glycoprotein 1
miRNA	microRNA
MMP	matrix metalloprotease
MRTFs	myocardin-related transcription factors
NETs	neutrophil extracellular traps
NK	natural killer
PAI-1	plasminogen activator inhibitor-1
POSAS	patient and observer scar assessment scale
PPAR	peroxisome proliferator-activated receptor
PRP	platelet-rich plasma
PRRs	pattern-recognition receptors
RAGE	receptor for advanced glycation end
Rv	resolvins
RXR	retinoid X receptor
SMURF	Smad ubiquitination regulatory factor 2
SSc	systemic skin sclerosis
TAZ	transcriptional coactivator with PDZ-binding motif
TGF-β	transforming growth factor-beta
TIMP	tissue inhibitors of metalloproteinase
TMF	trimethoxy-isoflavone
TNF-α	tumor necrosis factor-alpha
TRIM	tripartite-motif
TSA	trichostatin A
TTC3	tetratricopeptide repeat domain 3
VSS	Vancouver Scar Scale
YAP1	Yes-associated protein 1
α-SMA	α-smooth muscle actin